Another novel adipokine is fibroblast growth factor 21 (FGF21), which has been reported to have beneficial effects on glucose homeostasis and insulin sensitivity in animal studies [16], [17], and reports on FGF21 in GDM were limited and controversial [18], [19]. The gene discussed is INS; the disease is gestational diabetes.